PUBLIC COMPANY
saveGLAXOSMITHKLINE
USupdated 3mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- phase2A Study of GSK5864399 Administered Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumours
- phase2A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- phase3A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- phase2A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- phase3Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- phase3A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- phase3A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
🐶 Hiring Signal
News
- Ramaswamy’s biotech baggage haunted his political runA pivotal Alzheimer’s trial tied to Vivek Ramaswamy’s political rise is a tale of failed endpoints.biopharma_dive · 10d ago
- STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and moreA U.S. judge rejected a bid to block Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugsstat · 23d ago
- Recon: FDA approves GSK hepatitis B drug; EQT to buy molecular testing firm Qiagen for $10.8BWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 28d ago
- Chai Discovery signs GSK deal to make biologics with AIAt the start of 2026, Joshua Meier pitched his startup's collaboration with Eli Lilly as just the beginning. Meier's vision of a "year of deployment" has been more than an aspiration, as ...endpoints · 1mo ago
- No more Nordisk as Novo goes it alone amid rebranding pushAs Novo Nordisk continues its epic battle with Eli Lilly for market share in the increasingly competitive obesity and diabetes space, Novo is launching a major rebrand of its business, logo and name.fiercebiotech · 2mo ago
- TwinStrand wins patent case; GSK’s hepatitis B drug approved in JapanTwinStrand Biosciences wins patent case: The DNA sequencing company, which spun out of the University of Washington, announced on Monday that it won a patent infringement lawsuit against a Californ…endpoints · 2mo ago
- FDA approves Nuvalent's cancer drug, a week after GSK closed $10.6B buyoutGSK's $10.6 billion acquisition of Nuvalent is delivering surprisingly early results. The FDA on Wednesday approved one of Nuvalent's lung cancer medicines two months earlier than projected, and th…endpoints · 4mo ago
- STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and moreThe number of active medication shortages in the U.S. rose to 227 in the second quarter of 2026stat · 4mo ago
- Beyond Boston: Unlikely cities stake biotech claimsAs Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.biopharma_dive · 4mo ago
- Ex-iTeos CEO starts fresh at GSK neuro partner; Genentech loses yet another key scientist→ Michel Detheux has succeeded Rita Balice-Gordon as CEO of Danish neuro biotech Muna Therapeutics, which is partnering with GSK on Alzheimer’s treatments. Balice-Gordon will slide over to ...endpoints · 4mo ago
comments(0)
5-min edit window · permanent after that